These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31692593)

  • 1. MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis.
    Nan P; Niu Y; Wang X; Li Q
    Onco Targets Ther; 2019; 12():6917-6925. PubMed ID: 31692593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
    Zhang Y; Yang L; Wang S; Liu Z; Xiu M
    Cancer Biomark; 2018; 22(1):151-159. PubMed ID: 29630527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-196a promoted cell migration, invasion and the epithelial-mesenchymal transition by targeting HOXA5 in osteosarcoma.
    Wang X; Zhang L; Zhang X; Xing C; Liu R; Zhang F
    Cancer Biomark; 2020; 29(2):291-298. PubMed ID: 32675397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells.
    Chen Y; Zhang W; Yan L; Zheng P; Li J
    PeerJ; 2020; 8():e10148. PubMed ID: 33150075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1.
    Gong Y; Wan JH; Zou W; Lian GY; Qin JL; Wang QM
    Future Oncol; 2019 May; 15(15):1729-1744. PubMed ID: 31038361
    [No Abstract]   [Full Text] [Related]  

  • 6. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
    Zhang L; Wang X; Chen P
    BMC Cancer; 2013 Jun; 13():290. PubMed ID: 23768087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
    Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
    Chen R; Zhang L
    Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT.
    Li W; Jiang Y; Pan Q; Yang G
    Adv Clin Exp Med; 2023 May; 32(5):575-582. PubMed ID: 36530029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer.
    Li Y; Wang Z; Li Y; Jing R
    Oncol Lett; 2017 May; 13(5):3896-3904. PubMed ID: 28521487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2.
    Jiang T; Sui D; You D; Yao S; Zhang L; Wang Y; Zhao J; Zhang Y
    Cell Cycle; 2018; 17(10):1268-1278. PubMed ID: 29888640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3.
    Wang Y; Hu J; Qi G; Wang S; Gao J
    J BUON; 2020; 25(4):2028-2035. PubMed ID: 33099949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC.
    Zou T; Gao Y; Qie M
    Ann Transl Med; 2021 Jan; 9(2):125. PubMed ID: 33569427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial-mesenchymal transition in liver cancer cells.
    Zhang H; Wang Y; Ding H
    Clin Transl Oncol; 2021 Oct; 23(10):2078-2089. PubMed ID: 33891266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting MicroRNA-29a Protects Myocardial Ischemia-Reperfusion Injury by Targeting SIRT1 and Suppressing Oxidative Stress and NLRP3-Mediated Pyroptosis Pathway.
    Ding S; Liu D; Wang L; Wang G; Zhu Y
    J Pharmacol Exp Ther; 2020 Jan; 372(1):128-135. PubMed ID: 31481517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29a Inhibits Growth, Migration and Invasion of Melanoma A375 Cells in Vitro by Directly Targeting BMI1.
    Xiong Y; Liu L; Qiu Y; Liu L
    Cell Physiol Biochem; 2018; 50(1):385-397. PubMed ID: 30286469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-29a-3p, Up-Regulated in Human Gastric Cells and Tissues with H.Pylori Infection, Promotes the Migration of GES-1 Cells via A20-Mediated EMT Pathway.
    Sun F; Ni Y; Zhu H; Fang J; Wang H; Xia J; Ding F; Shen H; Shao S
    Cell Physiol Biochem; 2018; 51(3):1250-1263. PubMed ID: 30485838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
    Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.